SpringerPlus · 2016 · 35 citations · 32 references
MedicineOncologySurgeryGastrointestinal OncologySurgical OncologyTumor PathologyBiliary Tract CancerCancer BiomarkersPreoperative Oncology AssessmentTumor CharacterizationTumor MarkersTumor-associated AntigensCancer Antigen 125Cancer Antigen 19-9Positive Predictive ValuePrognostic BiomarkersPrognostic Tumor MarkersSerum Tumor MarkersSurgical ResectabilityTumor Marker Cutoff Values
BACKGROUND: To examine the predictive value of tumor markers for evaluating tumor resectability in patients with hilar cholangiocarcinoma and to explore the prognostic effect of various preoperative factors on resectability in patients with potentially resectable tumors. Patients with potentially resectable tumors judged by radiologic examination were included. The receiver operating characteristic (ROC) analysis was conducted to evaluate serum carbohydrate antigenic determinant 19-9 (CA 19-9), carbohydrate antigen 125 (CA 125) and carcino embryonie antigen levels on tumor resectability. Univariate and multivariate logistic regression models were also conducted to analysis the correlation of preoperative factors with resectability. RESULTS: In patients with normal bilirubin levels, ROC curve analysis calculated the ideal CA 19-9 cut-off value of 203.96 U/ml in prediction of resectability, with a sensitivity of 83.7 %, specificity of 80 %, positive predictive value of 91.1 % and negative predictive value of 66.7 %. Meanwhile, the optimal cut-off value for CA 125 to predict resectability was 25.905 U/ml (sensitivity, 78.6 %; specificity, 67.5 %). In a multivariate logistic regression model, tumor size ≤3 cm (OR 4.149, 95 % CI 1.326-12.981, P = 0.015), preoperative CA 19-9 level ≤200 U/ml (OR 20.324, 95 % CI 6.509-63.467, P < 0.001), preoperative CA 125 levels ≤26 U/ml (OR 8.209, 95 % CI 2.624-25.677, P < 0.001) were independent determinants of resectability in patients diagnosed as hilar cholangiocarcinoma. CONCLUSIONS: Preoperative CA 19-9 and CA 125 levels predict resectability in patients with radiological resectable hilar cholangiocarcinoma. Increased preoperative CA 19-9 levels and CA 125 levels are associated with poor resectability rate.
32
Staging, Resectability, and Outcome in 225 Patients With Hilar Cholangiocarcinoma
William R. Jarnagin, Yuman Fong, Ronald P. DeMatteo et al. · Annals of Surgery · 2001 · 1.4K citations
New staging system and a registry for perihilar cholangiocarcinoma
Michelle L. DeOliveira, Richard D. Schulick, Yuji Nimura et al. · Hepatology · 2011 · 315 citations · Full text